| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
868,994 |
|
|
Indirect Shares
|
241,951 |
|
|
| Direct
Value |
$900,729,661 |
|
|
|
Indirect Value
|
$250,787,051 |
|
|
| Total
Shares |
1,110,945 |
|
|
| Total
Value |
$1,151,516,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-06-10 |
868,994 |
2024-06-10 |
241,951 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
147 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,427 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-06-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-08-27 |
4 |
D |
$351.33 |
$1,906,317 |
D/D |
(5,426) |
500,294 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,264 |
500,847 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-12-16 |
4 |
OE |
$52.03 |
$99,950 |
D/D |
1,921 |
501,921 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-12-16 |
4 |
OE |
$30.63 |
$99,976 |
D/D |
3,264 |
503,264 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-08-27 |
4 |
OE |
$314.31 |
$1,797,853 |
D/D |
5,720 |
505,720 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-02-24 |
4 |
AS |
$420.17 |
$49,631,741 |
D/D |
(118,123) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-10 |
4 |
AS |
$461.79 |
$55,428,041 |
D/D |
(117,815) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-12-12 |
4 |
OE |
$21.25 |
$5,212,519 |
D/D |
245,295 |
521,876 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-11-02 |
4 |
AS |
$561.75 |
$24,778,125 |
D/D |
(43,348) |
543,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
563,094 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2008-12-16 |
4 |
AS |
$16.40 |
$442,652 |
D/D |
(26,991) |
563,094 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-11-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,313 |
566,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-11-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,612 |
567,976 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
568,343 |
568,343 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-08-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
294 |
568,637 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,264 |
569,588 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-12-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,921 |
569,897 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-10-30 |
4 |
D |
$559.08 |
$53,739,888 |
D/D |
(96,122) |
586,696 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2008-12-16 |
4 |
D |
$16.42 |
$785,993 |
D/D |
(47,868) |
588,235 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-12-15 |
4 |
D |
$380.09 |
$40,157,269 |
D/D |
(105,652) |
591,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
118,993 |
602,594 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-11-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
43,348 |
612,936 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2009-12-03 |
4 |
D |
$19.29 |
$1,309,019 |
D/D |
(67,860) |
620,375 |
0 |
- |
|
147 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
